全球数位基因组学市场按产品、应用、最终用户和地区划分

2025 年全球数位基因体学市场价值预估为 353.5 亿美元，预计到 2032 年将达到 847.8 亿美元，2025 年至 2032 年的复合年增长率为 13.3%。

数字。 2025 年数位基因体学市场占有率（%），依地区划分

受基因序列测定和资料分析成本下降的推动，全球数位基因组学市场预计将在未来十年大幅增长。高通量 DNA 定序技术的进步使研究人员能够以前所未有的速度和经济性对整个人类基因组进行定序。这加速了遗传疾病研究、药物研发、精准医疗和诊断等多个领域的研究。一些公司正在开发结合次世代定序仪定序平台、先进的生物资讯学工具和临床决策支援系统的整合解决方案。该技术有望透过基于个人独特基因特征的早期疾病检测和标靶治疗方法来改变医疗保健领域。

市场动态：

由于多种因素，全球数位基因组学市场正在经历强劲成长。 DNA测序技术成本的下降，以及提供更高通量、更长读取距离的第三代定序平台的出现，正在降低基因测序的成本。这使得基因组分析更适用于临床应用。政府和私人组织对基因组研究的资助增加也刺激了数位基因组解决方案的采用。然而，围绕共用基因组资料的监管和道德问题带来了挑战。缺乏熟练人力和处理大型基因组资料集的技术挑战也限制了市场的发展。整合基因组资料的临床决策支援系统的开发代表着一个巨大的商机。用于储存、分析和管理基因组资料的云端基础的平台有可能加速精准医疗方法的发展。

本研究的主要特点

本报告对全球数位基因组市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和復合年增长率。

它还强调了各个领域的潜在商机并解释了该市场的有吸引力的投资提案矩阵。

它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。

全球数位基因组学市场的主要企业是根据公司亮点、产品系列、关键亮点、性能和策略等参数进行的分析。

主要公司包括 Illumina、Thermo Fisher Scientific、Qiagen、Agilent Technologies 和 F. Hoffmann-La Roche。

本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。

全球数位基因组市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。

相关人员可以透过用于分析全球数位基因组学市场的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 影响分析
• 市场趋势
• 主要进展
• 监管情景
• 收购和合作场景
• 资金筹措和投资
• PEST分析
• 波特的分析

第 4 章全球数位基因体学市场：COVID-19 疫情的影响

• 整体影响
• 政府倡议
• COVID-19 市场影响

第 5 章。全球数位基因组学市场按产品划分（2020-2032 年）

• 定序和分析仪器
• DNA/RNA 分析套件
• 定序晶片
• 定序和分析软体
• 样品製备设备

6. 全球数位基因体学市场按应用划分（2020-2032 年）

• 临床
• 生殖健康
• 肿瘤学
• 心血管疾病
• 神经系统疾病
• 法医学
• 药物研发
• 其他的

7. 全球数位基因组学市场（按最终用户划分） (2020-2032)

• 医院
• 诊断中心和法医学实验室
• 研究所
• 其他的

8. 全球数位基因体学市场按地区划分（2020-2032 年）

• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第九章 竞争格局

• 公司简介
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • QIAGEN
  • GenomeMe Inc.
  • NanoString Technologies, Inc.
  • Agilent Technologies
  • Becton Dickinson（BD）
  • bioMerieux SA
  • Pacific Biosciences
  • PerkinElmer Inc.
  • GE Healthcare
  • Invitae Corporation
  • GenMark Diagnostics, Inc.
  • Inscripta, Inc.
  • 10x Genomics
  • Oxford Nanopore Technologies
  • Myriad Genetics.

第 10 章分析师建议

• 命运之轮
• 分析师观点
• Coherent Opportunity Map（COM）

第 11 章调查方法

• 参考
• 调查方法

Global Digital Genome Market is estimated to be valued at USD 35.35 Bn in 2025 and is expected to reach USD 84.78 Bn by 2032, growing at a compound annual growth rate (CAGR) of 13.3% from 2025 to 2032.

Figure. Digital Genome Market Share (%), By Region 2025

The global digital genome market is set to grow substantially over the next decade driven by declining costs of genomic sequencing and data analysis. Advancements in technologies for high-throughput DNA sequencing are enabling researchers to sequence entire human genomes at an unprecedented speed and affordable costs. This has accelerated research in various domains including genetic disease research, drug discovery, precision medicine, and diagnostics. Several companies are developing integrated solutions combining next-generation sequencing platforms, advanced bioinformatics tools, and clinical decision support systems. This is expected to transform the healthcare sector by enabling early disease detection and targeted treatment approaches based on an individual's unique genetic profile.

Market Dynamics:

The global digital genome market is witnessing strong growth driven by several factors. Declining costs of DNA sequencing technologies and emergence of third generation sequencing platforms that provide longer reads at higher throughput are reducing the costs of genome sequencing. This is making genomic analysis accessible for clinical applications. Growing funding for genomic research from government and private organizations is also fueling the adoption of digital genome solutions. However, regulatory and ethical issues related to genomic data sharing present a challenge. Lack of skilled workforce and technical challenges in handling huge genomic datasets pose restraints on the market. Development of clinical decision support systems integrated with genomic data presents a major opportunity. Cloud-based platforms for the storage, analysis, and management of genomic data could accelerate precision medicine approaches.

Key Features of the Study:

This report provides in-depth analysis of the global digital genome market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global digital genome market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, F. Hoffmann-La Roche

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global digital genome market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global digital genome market

Detailed Segmentation-

• By Product
  • Sequencing and Analyzer Instruments
  • DNA/RNA Analysis Kits
  • Sequencing Chips
  • Sequencing and Analysis Software
  • Sample Preparation Instruments
• By Application
  • Clinical
  • Reproductive Health
  • Oncology
  • Cardiovascular Diseases
  • Neurological Disorders
  • Others
  • Forensics
  • Drug Discovery and Development
  • Others
• By End User
  • Hospitals
  • Diagnostic Centers and Forensic Labs
  • Research Institutes
  • Others
• Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • QIAGEN
  • GenomeMe Inc.
  • NanoString Technologies, Inc.
  • Agilent Technologies
  • Becton Dickinson (BD)
  • bioMerieux SA
  • Pacific Biosciences
  • PerkinElmer Inc.
  • GE Healthcare
  • Invitae Corporation
  • GenMark Diagnostics, Inc.
  • Inscripta, Inc.
  • 10x Genomics
  • Oxford Nanopore Technologies
  • Myriad Genetics

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Digital Genome Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Digital Genome Market, By Product, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Sequencing and Analyzer Instruments
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• DNA/RNA Analysis Kits
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Sequencing Chips
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Sequencing and Analysis Software
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Sample Preparation Instruments
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Digital Genome Market, By Application, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Clinical
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Reproductive Health
• Oncology
• Cardiovascular Diseases
• Neurological Disorders
• Others
• Forensics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Drug Discovery and Development
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Digital Genome Market, By End User, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diagnostic Centers and Forensic Labs
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Research Institutes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Digital Genome Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Thermo Fisher Scientific Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • F. Hoffmann-La Roche Ltd
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Illumina, Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • QIAGEN
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • GenomeMe Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • NanoString Technologies, Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Agilent Technologies
  • Becton Dickinson (BD)
  • bioMerieux SA
  • Pacific Biosciences
  • PerkinElmer Inc.
  • GE Healthcare
  • Invitae Corporation
  • GenMark Diagnostics, Inc.
  • Inscripta, Inc.
  • 10x Genomics
  • Oxford Nanopore Technologies
  • Myriad Genetics.

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. Research Methodology

• References
• Research Methodology
• About us and Sales Contact